Psychosomatic Research Center, Oral Oncology Center, São Paulo State University (UNESP), School of Dentistry, Araçatuba, São Paulo, Brazil.
Psychosomatic Research Center, Oral Oncology Center, São Paulo State University (UNESP), School of Dentistry, Araçatuba, São Paulo, Brazil; Department of Diagnosis and Surgery, Araçatuba Dental School, São Paulo State University (UNESP), Araçatuba, São Paulo, Brazil.
Arch Oral Biol. 2024 Jun;162:105939. doi: 10.1016/j.archoralbio.2024.105939. Epub 2024 Feb 29.
Psychological stressors have been related to tumor progression through the activation of beta-adrenergic receptors (β-AR) in several types of cancer.
This study aimed to investigate the expressions of β- and β-AR and their association with psychological and clinicopathological variables in patients with oral squamous cell carcinoma.
Tumor samples from 99 patients diagnosed with OSCC were subjected to immunohistochemical reaction to detect the expression of β-AR and β-AR. Anxiety and depression symptoms were assessed using the Beck Anxiety Inventory and Beck Depression Inventory (BDI), respectively. The Brunel Mood Scale was used for measuring affective mood states.
Univariate analyzes revealed that higher expression of β-AR was associated with increased alcohol consumption (p = 0.032), higher education (p = 0.042), worse sleep quality (p = 0.044) and increased levels of pain related to the primary tumor (p < 0.001). Higher expression of β-AR was related with regional metastasis (p = 0.014), increased levels of pain related to the primary tumor (p = 0.044), anxiety (p < 0.001) and depressive (p = 0.010) symptoms and higher mood scores of angry (p = 0.010) and fatigue (p = 0.010). Multivariate analysis identified that patients with advanced clinical stage had lower β-AR expression (OR=0.145, 95% CI=0.025-0.828, p = 0.003). Higher anxiety symptoms and higher mood fatigue are independent factors for increased β-AR expression (OR=4256, 95% CI=1439-12606, p = 0.009; OR=3816, 95% CI=1258-11,573, p = 0.018, respectively).
This study reveal that anxiety, fatigue symptoms, and clinical staging are associated with tumor expression of beta-adrenergic receptors in patients with oral cancer.
β-肾上腺素能受体(β-AR)在多种类型的癌症中通过激活β-AR,与肿瘤进展有关。
本研究旨在探讨β-AR和β-AR在口腔鳞状细胞癌患者中的表达及其与心理和临床病理变量的关系。
对 99 例口腔鳞状细胞癌患者的肿瘤标本进行免疫组织化学反应,以检测β-AR和β-AR的表达。分别使用贝克焦虑量表和贝克抑郁量表评估焦虑和抑郁症状。使用布鲁内尔情绪量表测量情感情绪状态。
单因素分析显示,β-AR高表达与饮酒量增加(p=0.032)、受教育程度较高(p=0.042)、睡眠质量较差(p=0.044)和与原发性肿瘤相关的疼痛水平升高有关(p<0.001)。β-AR高表达与区域转移(p=0.014)、与原发性肿瘤相关的疼痛水平升高(p=0.044)、焦虑(p<0.001)和抑郁(p=0.010)症状以及愤怒(p=0.010)和疲劳(p=0.010)的情绪评分升高有关。多因素分析显示,临床分期较晚的患者β-AR表达水平较低(OR=0.145,95%CI=0.025-0.828,p=0.003)。较高的焦虑症状和较高的情绪疲劳是β-AR表达增加的独立因素(OR=4256,95%CI=1439-12606,p=0.009;OR=3816,95%CI=1258-11573,p=0.018)。
本研究表明,焦虑、疲劳症状和临床分期与口腔癌患者肿瘤β-肾上腺素能受体的表达有关。